Kyle Concannon
The University of Texas MD Anderson Cancer Center · 51 works · 2,875 citations · h-index 9
Top works
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes
- Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
- Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer
- Outcomes Among Homeless Patients With Non–Small-Cell Lung Cancer: A County Hospital Experience
- Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways
- Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
- Chylopericardium and chylous effusions during treatment with selective RET inhibitors, selpercatinib and pralsetinib, in non-small cell lung cancer (NSCLC).
- Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets
- DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer
- Abstract A75: Circulating tumor cells in human breast cancer exhibit dynamic changes in epithelial and mesenchymal composition
- Outcomes among patients with a history of substance abuse in non-small cell lung cancer: A county hospital experience.
- Breast cancer screening in patients with cancers other than breast
- A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or Metastatic Neuroendocrine Non–Small-Cell Lung Cancer
- The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC–High SCLC
- Activating Mutations of Insulin Receptor Substrate 2 (IRS2) in Patients with Tyrosine Kinase Inhibitor-Refractory Chronic Myeloid Leukemia
- Abstract 1263: Reconstructing small cell lung cancer evolution using deep whole genome sequencing of circulating tumor DNA
- Differential predictive impact of PD-L1 expression on immunotherapy outcomes and immunophenotype in squamous versus non-squamous NSCLC.
- Increasing Provider Awareness Regarding Act 39 in Middlebury Vermont
- Homeless outcomes in non-small cell lung cancer: A county hospital experience.